Stocks of Titan Pharmaceuticals, Inc. (de) (TTNP) are poised to climb above their peers

With 0.67 million shares changed hands, the volume of the stock remained heavier than its average volume of 35510.0 shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $5.1499 whereas the lowest price it dropped to was $4.8711. The 52-week range on TTNP shows that it touched its highest point at $6.99 and its lowest point at $3.03 during that stretch. It currently has a 1-year price target of $27.00. Beta for the stock currently stands at 1.42.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TTNP was down-trending over the past week, with a drop of -1.96%, but this was up by 14.16% over a month. Three-month performance surged to 7.53% while six-month performance rose 35.50%. The stock gained 53.37% in the past year, while it has lost -37.50% so far this year.

Float and Shares Shorts:

At present, 1.33 million TTNP shares are outstanding with a float of 0.95 million shares on hand for trading. On 2025-08-15, short shares totaled 27105.0, which was 203.99998999999997 higher than short shares on 1752537600. In addition to Mr. Weei Jye Chay as the firm’s Chief Executive Officer, Mr. Brynner Chiam serves as its Acting Principal Financial Officer & Director.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, TTNP reported revenue of $0.0 and operating income of $-657000.0. The EBITDA in the recently reported quarter was $-657000.0 and diluted EPS was $-0.65.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $-15.2 being high and $-15.2 being low. For TTNP, this leads to a yearly average estimate of $-15.2.

Sete News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.